BDBM752365 (1R,3S,5R)-2-(2-(3-acetyl- 7-(hydroxymethyl)-5-(2- methylpyrazolo[1,5-a]pyr- imidin-6-yl)-1H-indol-1- yl)acetyl)-5-methyl-N-(3- methyl-6-(trifluorometh- yl)pyridin-2-yl)-2-azabi- cyclo[3.1.0]hexane-3-car- boxamide::US20250197403, Compound 43

SMILES CC(=O)c1cn(CC(=O)N2[C@H](C(=O)Nc3nc(C(F)(F)F)ccc3C)C[C@@]3(C)C[C@@H]23)c2c(CO)cc(-c3cnc4cc(C)nn4c3)cc12

InChI Key

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 752365   

TargetComplement factor D(Human)
Achillion Pharmaceuticals

US Patent
LigandPNGBDBM752365((1R,3S,5R)-2-(2-(3-acetyl- 7-(hydroxymethyl)-5-(2-...)
Affinity DataIC50: 1.00E+3nMAssay Description:Human Factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/14/2025
Entry Details
US Patent